Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,946 | -50,874 | -39,241 | -26,366 | -11,917 |
| Depreciation Amortization | 271 | 793 | 568 | 406 | 233 |
| Accounts payable and accrued liabilities | -482 | 1,124 | 940 | 1,726 | 1,493 |
| Other Working Capital | -2,244 | -644 | -92 | 1,474 | -162 |
| Other Operating Activity | 4,477 | 10,210 | 7,691 | 3,948 | 1,165 |
| Operating Cash Flow | $-11,924 | $-39,391 | $-30,134 | $-18,812 | $-9,188 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -67,214 | -56,041 | -33,590 | -8,923 |
| PPE Investments | N/A | -38 | -40 | -16 | -16 |
| Sale Of Investment | 15,750 | 33,750 | 13,500 | 6,750 | N/A |
| Other Investing Activity | 39 | -22 | -22 | -9 | -3 |
| Investing Cash Flow | $15,789 | $-33,524 | $-42,603 | $-26,865 | $-8,942 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 402 | 403 | N/A | 116 | N/A |
| Debt Issued | N/A | 15,000 | 15,000 | 15,000 | 15,000 |
| Debt Repayment | -833 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 64 | 33,051 | 32,772 | 32,677 | 480 |
| Other Financing Activity | -116 | -1,654 | -1,491 | -1,396 | -1,380 |
| Financing Cash Flow | $-483 | $46,800 | $46,281 | $46,397 | $14,100 |
| Beginning Cash Position | 22,536 | 48,651 | 48,651 | 48,651 | 48,651 |
| End Cash Position | 25,918 | 22,536 | 22,195 | 49,371 | 44,621 |
| Net Cash Flow | $3,382 | $-26,115 | $-26,456 | $720 | $-4,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,924 | -39,391 | -30,134 | -18,812 | -9,188 |
| Capital Expenditure | N/A | -40 | -40 | -16 | -16 |
| Free Cash Flow | -11,924 | -39,431 | -30,174 | -18,828 | -9,204 |